US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma-March 2024-www.financetom.com

US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves Bristol Myers Squibb's cancer drug for Hodgkin's lymphoma

Mar 20, 2026 9:40 AM

March 20 (Reuters) - The U.S. Food and Drug

Administration on Friday approved Bristol Myers Squibb's ( BMY )

combination treatment for adults and adolescents aged 12 and

older with previously untreated Stage III or IV classical

Hodgkin's lymphoma.

Previous page： Pagaya Technologies Insider Sold Shares Worth $1,025,463, According to a Recent SEC Filing Next page： Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Pagaya Technologies Insider Sold Shares Worth $1,025,463, According to a Recent SEC Filing

Jun 16, 2025

05:24 PM EDT, 06/16/2025 (MT Newswires) -- Avital Pardo, Director, Chief Technology Officer, on June 12, 2025, sold 53,852 shares in Pagaya Technologies ( PGY ) for $1,025,463. Following the Form 4 filing with the SEC, Pardo has control over a total of 1,110,220 Class B common shares of the company, with 1,110,220 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1883085/000188308525000109/xslF345X05/wk-form4_1750108587.xml ...

Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer

Jun 16, 2025

-Regeneron Pharmaceuticals ( REGN ) has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning bid of $256 million, a company spokesperson told Reuters on Monday. WHY IT'S IMPORTANT Co-founder Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron's offer for the...

Pagaya Technologies Insider Sold Shares Worth $1,030,686, According to a Recent SEC Filing

Jun 16, 2025

05:23 PM EDT, 06/16/2025 (MT Newswires) -- Yahav Yulzari, Director, Chief Business Officer, on June 12, 2025, sold 54,125 shares in Pagaya Technologies ( PGY ) for $1,030,686. Following the Form 4 filing with the SEC, Yulzari has control over a total of 4,153,550 Class B common shares of the company, with 4,153,550 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1883085/000188308525000110/xslF345X05/wk-form4_1750108628.xml ...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...